Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

被引：23

作者：

Yoshino, T. ^{[1
]}

Cervantes, A. ^{[2
,3
]}

Bando, H. ^{[1
]}

Martinelli, E. ^{[4
]}

Oki, E. ^{[5
]}

Xu, R. -H. ^{[6
]}

Mulansari, N. A. ^{[7
]}

Babu, K. Govind ^{[8
,9
]}

Lee, M. A. ^{[10
]}

Tan, C. K. ^{[11
]}

Cornelio, G. ^{[12
]}

Chong, D. Q. ^{[13
]}

Chen, L. -T. ^{[14
,15
,16
]}

Tanasanvimon, S. ^{[17
]}

Prasongsook, N. ^{[18
]}

Yeh, K. -H. ^{[19
,20
]}

Chua, C. ^{[13
]}

Sacdalan, M. D. ^{[21
]}

Sow , W. J. ^{[22
]}

Kim, S. T. ^{[23
]}

Chacko, R. T. ^{[24
]}

Syaiful, R. A. ^{[25
]}

Zhang, S. Z. ^{[26
]}

Curigliano, G. ^{[27
,28
]}

Mishima, S. ^{[1
]}

Nakamura, Y. ^{[1
]}

Ebi, H. ^{[29
]}

Sunakawa, Y. ^{[30
]}

Takahashi, M. ^{[31
]}

Baba, E. ^{[32
]}

Peters, S. ^{[33
]}

Ishioka, C. ^{[34
]}

Pentheroudakis, G. ^{[35
]}

机构：

[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan

[2] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Oncol, Valencia, Spain

[3] Inst Salud Carlos III, CIBERONC, Madrid, Spain

[4] Univ Campania L Vanvitelli, Dept Precis Med, Oncol Unit, Naples, Italy

[5] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan

[6] Sun Yat Sen Univ, Dept Med Oncol, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China

[7] Univ Indonesia, Cipto Mangunkusumo Natl Gen Hosp, Dept Internal Med, Hematol Med Oncol Div, Jakarta, Indonesia

[8] HCG Hosp, Dept Med Oncol, Bengaluru, India

[9] St Johns Med Coll, Bengaluru, India

[10] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea

[11] Thomson Hosp Kota Damansara, Dept Oncol & Nucl Med, Petaling Jaya, Selangor, Malaysia

[12] Univ Philipppines, Philippine Gen Hosp, St Lukes Canc Inst Global City, Dept Med Oncol, Manila, Philippines

[13] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[14] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan

[15] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan

[16] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan

[17] Chulalongkorn Univ, Fac Med, Dept Internal Med, Bangkok, Thailand

[18] Phramongkutklao Hosp, Dept Med, Div Med Oncol, Bangkok, Thailand

[19] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[20] Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan

[21] Univ Philippines, Philippine Gen Hosp, Coll Med, Manila, Philippines

[22] Aurelius Hosp, Dept Radiotherapy & Oncol, Nilai, Malaysia

[23] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea

[24] Christian Med Coll & Hosp, Dept Med Oncol, Vellore, Tamil Nadu, India

[25] Univ Indonesia, Dr Cipto Mangunkusumo Natl Gen Hosp, Dept Surg, Jakarta, Indonesia

[26] Zhejiang Univ, Affiliated Hosp 2, Dept Colorectal Surg, Sch Med, Hangzhou, Zhejiang, Peoples R China

[27] IRCCS, Ist Europeo Oncol, Milan, Italy

[28] Univ Milan, Dept Oncol & Haematol, Milan, Italy

[29] Aichi Canc Ctr, Div Mol Therapeut, Res Inst, Nagoya, Japan

[30] St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Japan

[31] Tohoku Univ, Grad Sch Med, Dept Clin Oncol, Sendai, Japan

[32] Kyushu Univ, Grad Sch Med Sci, Dept Oncol & Social Med, Fukuoka, Japan

[33] Lausanne Univ Hosp CHUV, Oncol Dept, Lausanne, Switzerland

[34] Tohoku Univ Hosp, Dept Med Oncol, Sendai, Japan

[35] ESMO, Lugano, Switzerland

来源：

ESMO OPEN | 2023年 / 8卷 / 03期

关键词：

ESMO; guidelines; Pan-Asian; metastatic colorectal cancer; treatment; CETUXIMAB PLUS IRINOTECAN; MISMATCH REPAIR-DEFICIENT; POSITIVE SOLID TUMORS; PHASE-III TRIAL; WILD-TYPE KRAS; OPEN-LABEL; RANDOMIZED PHASE-3; 1ST-LINE TREATMENT; RAS MUTATIONS; RADIOFREQUENCY ABLATION;

D O I：

10.1016/j.esmoop.2023.101558

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer (mCRC), published in late 2022, were adapted in December 2022, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with mCRC. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with mCRC representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), co-ordinated by ESMO and the Japanese Society of Medical Oncology (JSMO). The voting was based on scientific evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different Asian countries. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with mCRC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials, whilst respecting the differences in screening practices, molecular profiling and age and stage at presentation, coupled with a disparity in the drug approvals and reimbursement strategies, between the different countries.

引用

页数：19

共 50 条

[1] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer
Kanesvaran, R.
Castro, E.
Wong, A.
Fizazi, K.
Chua, M. L. K.
Zhu, Y.
Malhotra, H.
Miura, Y.
Lee, J. L.
Chong, F. L. T.
Pu, Y-S
Yen, C-C
Saad, M.
Lee, H. J.
Kitamura, H.
Prabhash, K.
Zou, Q.
Curigliano, G.
Poon, E.
Choo, S. P.
Peters, S.
Lim, E.
Yoshino, T.
Pentheroudakis, G.
ESMO OPEN, 2022, 7 (04)
[2] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
Shitara, K.
Fleitas, T.
Kawakami, H.
Curigliano, G.
Narita, Y.
Wang, F.
Wardhani, S. O.
Basade, M.
Rha, S. Y.
Zamaniah, W. I. Wan
Sacdalan, D. L.
Ng, M.
Yeh, K. H.
Sunpaweravong, P.
Sirachainan, E.
Chen, M. -h.
Yong, W. P.
Peneyra, J. L.
Ibtisam, M. N.
Lee, K. -w.
Krishna, V.
Pribadi, R. R.
Li, J.
Lui, A.
Yoshino, T.
Baba, E.
Nakayama, I.
Pentheroudakis, G.
Shoji, H.
Cervantes, A.
Ishioka, C.
Smyth, E.
ESMO OPEN, 2024, 9 (02)
[3] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
Koppikar, S.
Oaknin, A.
Babu, K. Govind
Lorusso, D.
Gupta, S.
Wu, L. -Y.
Rajabto, W.
Harano, K.
Hong, S. -h.
Malik, R. A.
Strebel, H.
Aggarwal, I. M.
Lai, C. -H.
Dejthevaporn, T.
Tangjitgamol, S.
Cheng, W. F.
Chay, W. Y.
Benavides, D.
Hashim, N. M.
Moon, Y. W.
Yunokawa, M.
Anggraeni, T. D.
Wei, W.
Curigliano, G.
Maheshwari, A.
Mahantshetty, U.
Sheshadri, S.
Peters, S.
Yoshino, T.
Pentheroudakis, G.
ESMO OPEN, 2023, 8 (01)
[4] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
Chen, L. -T
Vogel, A.
Hsu, C.
Chen, M. -h.
Fang, W.
Pangarsa, E. A.
Sharma, A.
Ikeda, M.
Park, J. O.
Tan, C. K.
Regala, E.
Tai, D.
Tanasanvimon, S.
Charoentum, C.
Chee, C. E.
Lui, A.
Sow, J.
Oh, D. -y.
Ueno, M.
Ramaswamy, A.
Jeo, W. S.
Zhou, J.
Curigliano, G.
Yoshino, T.
Bai, L. -y.
Pentheroudakis, G.
Chiang, N. -j.
Cervantes, A.
Chen, J. -s.
Ducreux, M.
ESMO OPEN, 2024, 9 (08)
[5] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
Park, K. H.
Loibl, S.
Sohn, J.
Park, Y. H.
Jiang, Z.
Tadjoedin, H.
Nag, S.
Saji, S.
Yusof, M. Md.
Villegas, E. M. B.
Lim, E. H.
Lu, Y. -S.
Ithimakin, S.
Tseng, L. -M.
Dejthevaporn, T.
Chen, T. W. W.
Lee, S. C.
Galvez, C.
Malwinder, S.
Kogawa, T.
Bajpai, J.
Brahma, B.
Wang, S.
Curigliano, G.
Yoshino, T.
Kim, S. B.
Pentheroudakis, G.
Im, S. A.
Andre, F.
Ahn, J. B.
Harbeck, N.
ESMO OPEN, 2024, 9 (05)
[6] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
Yoshino, T.
Argiles, G.
Oki, E.
Martinelli, E.
Taniguchi, H.
Arnold, D.
Mishima
Li, Y.
Smruti, B. K.
Ahn, J. B.
Faud, I.
Chee, C. E.
Yeh, K. -h.
Lin, P. -c.
Chua, C.
Hasbullah, H. H.
Lee, M. A.
Sharma, A.
Sun, Y.
Curigliano, G.
Bando, H.
Lordick, F.
Yamanaka, T.
Tabernero, J.
Baba, E.
Cervantes, A.
Ohtsu, A.
Peters, S.
Ishioka, C.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2021, 32 (12) : 1496 - 1510
[7] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma
Kanesvaran, R.
Porta, C.
Wong, A.
Powles, T.
Ng, Q. S.
Schmidinger, M.
Ye, D.
Malhotra, H.
Miura, Y.
Lee, J. L.
Chong, F. L. T.
Pu, Y-S
Yen, C-C
Saad, M.
Lee, H. J.
Kitamura, H.
Bhattacharyya, G. S.
Curigliano, G.
Poon, E.
Choo, S. P.
Peters, S.
Lim, E.
Yoshino, T.
Pentheroudakis, G.
ESMO OPEN, 2021, 6 (06)
[8] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
Im, S. -A.
Gennari, A.
Park, Y. H.
Kim, J. H.
Jiang, Z. -F.
Gupta, S.
Fadjari, T. H.
Tamura, K.
Mastura, M. Y.
Abesamis-Tiambeng, M. L. T.
Lim, E. H.
Lin, C. -H.
Sookprasert, A.
Parinyanitikul, N.
Tseng, L. -M.
Lee, S. -C.
Caguioa, P.
Singh, M.
Naito, Y.
Hukom, R. A.
Smruti, B. K.
Wang, S. -S.
Kim, S. B.
Lee, K. -H.
Ahn, H. K.
Peters, S.
Kim, T. W.
Yoshino, T.
Pentheroudakis, G.
Curigliano, G.
Harbeck, N.
ESMO OPEN, 2023, 8 (03)
[9] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer (vol 9, 103647, 2024)
Chen, L. -T.
Vogel, A.
Hsu, C.
Chen, M. -H.
Fang, W.
Pangarsa, E. A.
Sharma, A.
Ikeda, M.
Park, J. O.
Tan, C. K.
Regala, E.
Tai, D.
Tanasanvimon, S.
Charoentum, C.
Chee, C. E.
Lui, A.
Sow, J.
Oh, D. -Y.
Ueno, M.
Ramaswamy, A.
Jeo, W. S.
Zhou, J.
Curigliano, G.
Yoshino, T.
Bai, L. -Y.
Pentheroudakis, G.
Chiang, N. -J.
Cervantes, A.
Chen, J. -S.
Ducreux, M.
ESMO OPEN, 2025, 10 (01)
[10] Pan-Asian adapted ESMO clinical practice guidelines
Huang, Jiefang
LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55

← 1 2 3 4 5 →